The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000277.3(PAH):c.1196_1199del (p.Val399fs)

CA229378

102551 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: cf002636-011c-4f50-b2ac-390b69cabf90

HGVS expressions

NM_000277.3:c.1196_1199del
NM_000277.3(PAH):c.1196_1199del (p.Val399fs)
NC_000012.12:g.102843649_102843652del
CM000674.2:g.102843649_102843652del
NC_000012.11:g.103237427_103237430del
CM000674.1:g.103237427_103237430del
NC_000012.10:g.101761557_101761560del
NG_008690.1:g.78954_78957del
NG_008690.2:g.119762_119765del
ENST00000553106.6:c.1196_1199del
ENST00000307000.7:c.1181_1184del
ENST00000549247.6:n.955_958del
ENST00000551114.2:n.858_861del
ENST00000553106.5:c.1196_1199del
ENST00000635477.1:n.300_303del
ENST00000635528.1:n.711_714del
NM_000277.1:c.1196_1199del
NM_000277.2:c.1196_1199del
NM_001354304.1:c.1196_1199del
NM_001354304.2:c.1196_1199del

Likely Pathogenic

Met criteria codes 4
PVS1_Strong PM3 PM2 PP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The NM_000277.3(PAH):c.1196_1199del (p.Val399Glyfs*52) is a frameshift variant in exon 11 of 13 that may cause loss of function of the protein, however it is predicted to escape nonsense mediated decay. Exon 13 is considered a critical region because it (along with Exon 12) forms the oligomerization domain (residues 411–452), which is responsible for the dimerization and tetramerization of the enzyme, important for regulation of PAH activity (PVS1_Strong). At least one patient (Case 154 in PMID: 8807331) with this variant had classical PKU with a serum phenylalanine level of 2131 μmol/L (above the >120 μmol/L requirement). Exclusion of a defect of BH4 cofactor metabolism was not reported (PP4). Case 154 (PMID: 8807331) is compound heterozygous for c.196_1199del and Arg408Trp (ClinVar 577, classified Pathogenic by the PAH VCEP; PM3). This variant is absent from gnomAD v2.1.1 (PM2). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive phenylketonuria based on the ACMG/AMP criteria applied, as specified by the ClinGen PAH VCEP: PVS1_strong, PP4, PM3, PM2. (PAH VCEP specifications version 1).
Met criteria codes
PVS1_Strong
The c.1196_1199del (p.Val399Glyfs*52) variant in PAH is a frameshift variant in exon 11 of 13 that may cause loss of function of the protein, however it is predicted to escape nonsense mediated decay, due to the resulting premature stop codon in exon 13, and therefore remove 0.4% of the protein. Exon 13 is considered a critical region because it (along with Exon 12) forms the oligomerization domain (residues 411–452), which is responsible for the dimerization and tetramerization of the enzyme, important for regulation of PAH activity (PVS1_Strong).
PM3
Case 154 (PMID: 8807331) is compound heterozygous for c.196_1199del and Arg408Trp (ClinVar 577, classified Pathogenic by the PAH VCEP; PM3).
PM2
This variant is absent from gnomAD v2.1.1 (PM2).
PP4
At least one patient (Case 154 in PMID: 8807331) with this variant had classical PKU with a serum phenylalanine level of 2131 umol/l (above the >120 μmol/L requirement). Exclusion of a defect of BH4 cofactor metabolism was not reported (PP4).
Approved on: 2022-10-14
Published on: 2022-10-14
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.